Increasing in a number of cancer cases and rise in geriatric population are the major factors which are attributing for the growth of tumor ablation market. As per the WHO statistics, cancer accounts for 13% of deaths globally every year, moreover, 70% increase in cancer incidences is anticipated over the next couple of decades. The global geriatric population is anticipated to nearly double from 12% to 22% from 2015 to 2022. Furthermore, increase in the number of hospitals, ablation and surgical centers, less procedural costs associated with radiofrequency ablation tumor and advanced technologies in ablation devices, improved healthcare expenditure, growing awareness, and increased government support are the few more factors which expected to boost the growth of tumor ablation market globally. A sample of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-tumor-ablation-market/#ulp-4H8Z4LpNMLEuOnnx[/URL]
Based on the function, the global tumor ablation market is segmented
• Automated/Robotic ablation
• Conventional ablation devices
Based on the technology, The Global Tumor Ablation Market is segmented
• Hyperthermic ablation
• Radiofrequency ablation
• Microwave ablation
• Laser ablation
• Ultrasound ablation
• Cryoablation
Based on the application, the global tumor ablation market is segmented
• Primary lung cancer
• Metastatic diseases
• Pain palliation
Based on the end user, the global tumor ablation market is segmented
• Hospitals
• Oncology institutes
• Diagnostic centres
To view TOC of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-tumor-ablation-market/#ulp-c654SbFYO64MsOhu[/URL]
Innovations in resources and technologies required in tumor ablation have provided an ample of opportunities for various pharma and electronics companies to work for the betterment of currently available technologies of tumor ablation. Innovations such as high intensity focussed ultrasound (HIFU), irreversible electroporation and image-guided procedures are rising demand for adaptation of tumor ablation. Moreover, increased focus on R&D investments, product developments, and launches, acquisitions, mergers, and collaborations are few strategies adopted by the players in the market. For exemplary, in 2016, Medtronic launchedBarrx360 express radiofrequency ablation balloon catheter to treat Barrett’s esophagus and in 2016 may, BTG Plc. has acquired Galil Medical, cryoablation systems, and needles manufacturer.
Need more information about this report @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-tumor-ablation-market/#ulp-14mlyhjMGhVjZqa3[/URL]
Some of the players in tumour ablation market are Boston Scientific Corporation (U.S.), Angiodynamics, Inc. (U.S.), BTG International Ltd (UK), Healthtronics, Inc. (U.S.), Medtronic, Plc (U.S.), EDAP TMS S.A. (France), Mermaid Medical, Inc. (Denmark), Neuwave Medical, Inc. (U.S.), Sonacare Medical, LLC (U.S.) and Mesonix, Inc. (U.S.).
Get access to full summary @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-tumor-ablation-market/[/URL]
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553